These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 12609561

  • 1. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
    Wuttke W, Seidlová-Wuttke D, Gorkow C.
    Maturitas; 2003 Mar 14; 44 Suppl 1():S67-77. PubMed ID: 12609561
    [Abstract] [Full Text] [Related]

  • 2. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study.
    Wuttke W, Gorkow C, Seidlová-Wuttke D.
    Menopause; 2006 Mar 14; 13(2):185-96. PubMed ID: 16645532
    [Abstract] [Full Text] [Related]

  • 3. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy?
    Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, Seidlová-Wuttke D.
    Maturitas; 2003 Mar 14; 44 Suppl 1():S9-20. PubMed ID: 12609555
    [Abstract] [Full Text] [Related]

  • 4. In vitro effects of the Cimicifuga racemosa extract BNO 1055.
    Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W.
    Maturitas; 2003 Mar 14; 44 Suppl 1():S31-8. PubMed ID: 12609557
    [Abstract] [Full Text] [Related]

  • 5. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa).
    Wuttke W, Jarry H, Haunschild J, Stecher G, Schuh M, Seidlova-Wuttke D.
    J Steroid Biochem Mol Biol; 2014 Jan 14; 139():302-10. PubMed ID: 23459142
    [Abstract] [Full Text] [Related]

  • 6. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
    Raus K, Brucker C, Gorkow C, Wuttke W.
    Menopause; 2006 Jan 14; 13(4):678-91. PubMed ID: 16837890
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus.
    Seidlová-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W.
    Maturitas; 2003 Mar 14; 44 Suppl 1():S39-50. PubMed ID: 12609558
    [Abstract] [Full Text] [Related]

  • 8. The Cimicifuga racemosa special extract BNO 1055 prevents hot flashes in ovariectomized rats.
    Kapur P, Wuttke W, Seidlova-Wuttke D.
    Phytomedicine; 2010 Sep 14; 17(11):890-4. PubMed ID: 20696560
    [Abstract] [Full Text] [Related]

  • 9. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.
    Hernández Muñoz G, Pluchino S.
    Maturitas; 2003 Mar 14; 44 Suppl 1():S59-65. PubMed ID: 12609560
    [Abstract] [Full Text] [Related]

  • 10. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K.
    Menopause; 2008 Mar 14; 15(1):51-8. PubMed ID: 18257142
    [Abstract] [Full Text] [Related]

  • 11. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.
    Winterhoff H, Spengler B, Christoffel V, Butterweck V, Löhning A.
    Maturitas; 2003 Mar 14; 44 Suppl 1():S51-8. PubMed ID: 12609559
    [Abstract] [Full Text] [Related]

  • 12. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
    Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer Ch, Birkhäuser M.
    Maturitas; 2005 Aug 16; 51(4):397-404. PubMed ID: 16039414
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.
    Nappi RE, Malavasi B, Brundu B, Facchinetti F.
    Gynecol Endocrinol; 2005 Jan 16; 20(1):30-5. PubMed ID: 15969244
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review.
    Laakmann E, Grajecki D, Doege K, zu Eulenburg C, Buhling KJ.
    Gynecol Endocrinol; 2012 Sep 16; 28(9):703-9. PubMed ID: 22385322
    [Abstract] [Full Text] [Related]

  • 15. Initial investigation into the optimal dose ratio of conjugated estrogens and bazedoxifene: a double-blind, randomized, placebo-controlled phase 2 dose-finding study.
    Pickar JH, Lavenberg J, Pan K, Komm BS.
    Menopause; 2018 Mar 16; 25(3):273-285. PubMed ID: 29088019
    [Abstract] [Full Text] [Related]

  • 16. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS, Mirkin S, Jenkins SN.
    Steroids; 2014 Nov 16; 90():71-81. PubMed ID: 24929044
    [Abstract] [Full Text] [Related]

  • 17. Effects of estradiol benzoate, raloxifen and an ethanolic extract of Cimicifuga racemosa in nonclassical estrogen regulated organs of ovariectomized rats.
    Seidlova-Wuttke D, Jarry H, Wuttke W.
    Planta Med; 2009 Oct 16; 75(12):1279-85. PubMed ID: 19350480
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.